Heme oxygenase-1 inhibits TNF-α-induced apoptosis in cultured fibroblasts

Irina Petrache1, Leo E. Otterbein2,1, Jawed Alam3, Gordon Wiegand1, Augustine M.K. Choi4,2
1The Johns Hopkins Medical Institution, Baltimore, Maryland 21205
2Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven 06250;
3Department of Molecular Genetics, Alton Ochsner Medical Foundation, and Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, New Orleans, Louisiana 70121; and
4Connecticut Veterans Affairs HealthCare Service, West Haven, Connecticut 06516;

Tóm tắt

Heme oxygenase (HO)-1 catalyzes the oxidative cleavage of heme to yield equimolar amounts of biliverdin, iron, and carbon monoxide. HO-1 is a stress response protein, the induction of which is associated with protection against oxidative stress. The mechanism(s) of protection is not completely elucidated, although it is suggested that one or more of the catalytic by-products provide antioxidant functions either directly or indirectly. The involvement of reactive oxygen species in apoptosis raised the question of a possible role for HO-1 in programmed cell death. Using the tetracycline-regulated expression system, we show here that conditional overexpression of HO-1 prevents tumor necrosis factor-α-induced apoptosis in murine L929 fibroblasts. Inhibition of apoptosis was not observed in the presence of tin protoporphyrin, a specific inhibitor of HO activity, and in cells overexpressing antisense HO-1. Interestingly, exogenous administration of a low concentration of carbon monoxide also prevented tumor necrosis factor-α-induced apoptosis in L929 fibroblasts. Inhibition of tumor necrosis factor-α-induced apoptosis by HO-1 overexpression was reversed by 1 H-(1,2,4)oxadiazolo(4,3- a)quinoxalin-1-one, an inhibitor of guanylate cyclase, which is a target enzyme for carbon monoxide. Taken together, our data suggest that the antiapoptotic effect of HO-1 may be mediated via carbon monoxide.

Từ khóa


Tài liệu tham khảo

Alam J., 1992, J. Biol. Chem., 267, 21894, 10.1016/S0021-9258(19)36696-7

10.1016/S0955-0674(99)80034-9

10.1038/sj.onc.1202568

Balla G., 1992, J. Biol. Chem., 267, 18148, 10.1016/S0021-9258(19)37165-0

10.1006/scbi.1995.0002

10.1006/excr.1996.0329

Camhi S. L., 1995, New Horiz., 3, 170

10.1152/ajplung.1998.275.4.L717

10.1165/ajrcmb.15.1.8679227

10.1128/MCB.7.2.725

El-Deiry W. S., 1994, Cancer Res., 54, 1169

10.1073/pnas.89.12.5547

10.1016/0042-6822(73)90341-3

10.1016/0006-291X(89)91745-2

10.1016/S0896-6273(00)80103-8

10.1126/science.275.5306.1649

10.1161/01.RES.84.3.253

10.1126/science.275.5303.1132

10.1016/S0167-5699(97)80014-X

Lafon C., 1996, Cell Growth Differ., 7, 1095

10.1073/pnas.93.19.10393

10.1073/pnas.91.16.7496

10.1111/j.1432-1033.1997.00725.x

10.1074/jbc.271.17.10205

10.1073/pnas.92.5.1475

10.1042/bj3100133

10.1165/ajrcmb.13.5.7576696

10.1172/JCI5342

10.1152/ajplung.1999.276.4.L688

10.1089/10430349950019138

10.1002/j.1460-2075.1987.tb02654.x

Pourzand C., 1997, Cancer Res., 67, 1405

10.1016/0014-5793(93)81423-W

10.1126/science.1378649

10.1073/pnas.82.23.7865

Shih S., 1996, Cancer Res., 56, 1591

Shultze-Osthoff K., 1992, J. Biol. Chem., 267, 5317, 10.1016/S0021-9258(18)42768-8

10.1038/2063

10.1128/MCB.15.5.2359

10.1073/pnas.91.7.2607

Vile G. F., 1994, J. Biol. Chem., 268, 14678, 10.1016/S0021-9258(18)82386-9

10.1126/science.275.5303.1129

Zimmerman R. J., 1989, Cancer Res., 49, 1644